Derek Jonker, MD
Ottawa Hospital and Research Institute · The Ottawa Hospital Cancer Centre · Ottawa Regional Cancer Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Derek Jonker, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:33 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT01394939 · Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaJennerex Biotherapeutics · completed · Colorectal Carcinoma, CRC · principal investigator
- Ph2NCT01237665 · IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal CancerOttawa Hospital Research Institute · unknown · Rectal Cancer · principal investigator
- Ph1NCT00107250 · AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)NCIC Clinical Trials Group · completed · Colorectal Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph3NCT00079066 · Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal CancerNCIC Clinical Trials Group · completed · Colorectal Cancer, Quality of Life · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.